Literature DB >> 32649076

Remdesivir for the Treatment of Covid-19 - Preliminary Report.

Zachary R McCaw1, Dae H Kim2, Lee-Jen Wei3.   

Abstract

Entities:  

Year:  2020        PMID： 32649076     DOI： 10.1056/NEJMc2022236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa.

Authors:  Youngji Jo; Lise Jamieson; Ijeoma Edoka; Lawrence Long; Sheetal Silal; Juliet R C Pulliam; Harry Moultrie; Ian Sanne; Gesine Meyer-Rath; Brooke E Nichols
Journal:  Open Forum Infect Dis       Date:  2021-01-29       Impact factor: 3.835
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.